Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · IEX Real-Time Price · USD
0.780
-0.010 (-1.25%)
At close: Mar 24, 2023, 3:11 PM
0.800
+0.020 (2.56%)
After-hours: Mar 24, 2023, 4:24 PM EDT
-1.25%
Market Cap 17.98M
Revenue (ttm) 490,878
Net Income (ttm) -2.57M
Shares Out 22.59M
EPS (ttm) -5.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,857
Open 0.770
Previous Close 0.790
Day's Range 0.770 - 0.807
52-Week Range 0.620 - 9.870
Beta -0.87
Analysts n/a
Price Target n/a
Earnings Date Mar 27, 2023

About SBFM

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatmen... [Read more]

Sector Healthcare
Founded 2006
Employees 3
Stock Exchange NASDAQ
Ticker Symbol SBFM
Full Company Profile

Financial Performance

In 2021, SBFM's revenue was $228,426, an increase of 219.88% compared to the previous year's $71,410. Losses were -$12.44 million, 346.7% more than in 2020.

Financial Statements

News

Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment

MONTREAL, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

3 weeks ago - GlobeNewsWire

Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound

MONTREAL, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

1 month ago - GlobeNewsWire

Sunshine Biopharma Announces Share Repurchase Program

MONTREAL, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

2 months ago - GlobeNewsWire

Sunshine Biopharma's Annual Letter to Shareholders

MONTREAL, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas includin...

3 months ago - GlobeNewsWire

4 Stocks Meeting GuruFocus' Value Screens in December

As investors prepare for the holiday season, GuruFocus' value screeners identified several stocks that meet screening criteria based on key principles taught by Benjamin Graham, Peter Lynch and Berksh...

Other symbols: RMCACCWFG
3 months ago - GuruFocus

Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project

MONTREAL, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas, includi...

4 months ago - GlobeNewsWire

Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue

MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drug...

5 months ago - GlobeNewsWire

Sunshine Biopharma Files Its Second Quarter Report With the SEC

Company Reports Significant Increase in Cash on Hand as a Result of Recent Financings Company Reports Significant Increase in Cash on Hand as a Result of Recent Financings

8 months ago - GlobeNewsWire

Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona

MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development an...

8 months ago - GlobeNewsWire

Sunshine Biopharma: An Opportunity Knocking?

Investors with a very high appetite for risk and seeking ultra-high-growth stocks can find potential opportunities within the pharma and biotech domain. Investing in development-stage biopharma compan...

11 months ago - GuruFocus

Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market

MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, developmen...

11 months ago - GlobeNewsWire

Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)

NEW YORK, NY / ACCESSWIRE / April 28, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ:SBFM) ...

11 months ago - Accesswire

Multiple Promising Treatments Accentuate the Bull Case for Sunshine Biopharma

SBFM stock is trading at a surprisingly low price, considering Sunshine Biopharma's demonstrably positive clinical results. The post Multiple Promising Treatments Accentuate the Bull Case for Sunshine...

11 months ago - InvestorPlace

Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, developmen...

11 months ago - GlobeNewsWire

Why Is Sunshine Biopharma (SBFM) Stock Up Today?

Today, investors in Sunshine Biopharma and SBFM stock are getting a huge boost from news that the company filed a patent for a key drug. The post Why Is Sunshine Biopharma (SBFM) Stock Up Today?

11 months ago - InvestorPlace

Why Sunshine Biopharma Stock Is Surging

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading higher Monday after the company announced it filed a United States provisional patent application covering the recently communicated mRNA molec...

11 months ago - Benzinga

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells

MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and ...

11 months ago - GlobeNewsWire

Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma

An SEC filing may have deterred some traders from holding SBFM stock. However, a closer look at the facts should clear up any confusion.

1 year ago - InvestorPlace

5 Stocks Halted In Tuesday's Session

A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to ...

Other symbols: DFFNLGHLSEV
1 year ago - Benzinga

Why Is Sunshine Biopharma (SBFM) Stock Down 30% Today?

Sunshine Biopharma's winning streak is likely finished due to confusion over an announcement. Here's why SBFM stock is down today.

1 year ago - InvestorPlace

Why Sunshine Biopharma Stock Is Falling Today

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading lower Friday morning after the company announced a common stock offering.  Sunshine Biopharma plans to offer on a resale basis an aggregate of ...

1 year ago - Benzinga

What's Going On With Sunshine Biopharma Stock Today?

Sunshine Biopharma Inc (NASDAQ: SBFM) is trading higher Wednesday on continued momentum after the company on Tuesday announced that two of its designed mRNA molecules are effective at destroying cance...

1 year ago - Benzinga

Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results

Montreal-based Sunshine Biopharma stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells. The post Sunshine Biopharma ...

1 year ago - InvestorPlace

Sunshine Biopharma Shares Are Soaring: Here's Why

Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown...

1 year ago - Benzinga

Sunshine Biopharma's Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments

1 year ago - GlobeNewsWire